Westover Capital Advisors LLC Buys Shares of 379 Intuitive Surgical, Inc. $ISRG

Westover Capital Advisors LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 2nd quarter, Holdings Channel.com reports. The institutional investor purchased 379 shares of the medical equipment provider’s stock, valued at approximately $206,000.

Other institutional investors have also recently made changes to their positions in the company. Nuveen LLC acquired a new stake in Intuitive Surgical during the 1st quarter worth approximately $1,715,899,000. Goldman Sachs Group Inc. increased its position in shares of Intuitive Surgical by 26.1% during the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock worth $1,396,496,000 after acquiring an additional 584,375 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Intuitive Surgical by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after acquiring an additional 566,979 shares during the period. Jennison Associates LLC raised its stake in shares of Intuitive Surgical by 20.4% in the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock valued at $1,696,738,000 after acquiring an additional 528,359 shares in the last quarter. Finally, Wellington Management Group LLP boosted its holdings in Intuitive Surgical by 15.0% in the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after purchasing an additional 457,080 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on ISRG shares. Daiwa Capital Markets increased their price target on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday, October 24th. Robert W. Baird set a $655.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, October 31st. Finally, Rothschild & Co Redburn raised their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $608.92.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Fredrik Widman sold 2,067 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $550.00, for a total value of $1,136,850.00. Following the transaction, the vice president directly owned 473 shares in the company, valued at approximately $260,150. The trade was a 81.38% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 116,164 shares of company stock valued at $61,916,172 over the last quarter. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Up 0.0%

Shares of ISRG opened at $546.77 on Wednesday. The company has a market capitalization of $196.00 billion, a price-to-earnings ratio of 72.32, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The stock has a 50 day moving average price of $485.63 and a 200 day moving average price of $503.34.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter last year, the company earned $1.84 earnings per share. The firm’s revenue for the quarter was up 22.9% on a year-over-year basis. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.